盐酸替罗非班氯化钠注射液与心血管介入治疗急性心肌梗死患者临床观察

Clinical Treatment of Tirofiban Hydrochloride and Sodium Chloride Injection and Cardiovascular Interventional in Patients With Acute Myocardial Infarction

目的探讨盐酸替罗非班氯化钠注射液与心血管介入治疗急性心肌梗死临床应用效果。方法对照组急性心肌梗死患者给予介入治疗,研究组给予介入治疗联合盐酸替罗非班氯化钠注射液给药,分析所得数据。结果研究组经介入术后TIMI分级3级者所占比例高达90.63%,高于对照组介入术后TIMI分级3级者所占比例75.00%(P<0.05);研究组心血管不良事件发生率仅为9.38%,低于对照组心血管不良事件发生率28.13%(P<0.05)。结论对急性心肌梗死患者给予精辟冠状动脉介入术联合盐酸替罗非班氯化钠注射液治疗可显著提高疗效及预后,有利于保障患者生活质量及生命安全。

Objective Discussion tirofiban hydrochloride and sodium chloride injection and cardiovascular interventional treatment of acute myocardial infarction clinical effect. Methods Acute myocardial infarction in the control group were treated with interventional therapy, interventional treatment of joint study group received tirofiban hydrochloride and sodium chloride injection is administered, and the resulting data were statistically analyzed after obtaining conclusions. Results Study Group proportion of up to 90.63% after intervention by the TIMI grade 3 were significantlyhigher than TIMI grade 3 after intervention by the proportion of 75.00%（P〈0.05）, the study group the incidence of cardiovascular events only 9.38%, significantly lower than the control group the incidence of cardiovascular events 28.13%（P〈0.05）. Conclusion Acute myocardial infarction patients given combined brilliantly coronary intervention tirofiban hydrochloride and sodium chloride injection therapy can significantly improve the efficacy and prognosis, quality of life and help protect the lives and safety of patients.